The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Heartworm Injections Market Research Report 2025
Synopsis
Heartworm injections are injections that are used to prevent and treat heartworm disease in dogs, cats, and other pets. They are administered by a veterinarian and are effective in preventing the development of heartworm infections in pets that are regularly treated. In addition, they can also be used to treat existing heartworm infections. These injections are administered on a regular basis, usually once or twice a month, and require a commitment from the pet owner to ensure effective treatment.
The global Heartworm Injections market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Heartworm Injections is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Heartworm Injections is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Heartworm Injections include Boehringer Ingelheim, Zoetis, Merck Animal Health, Elanco, Virbac and Ceva Sante Animale S.A., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Heartworm Injections, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Heartworm Injections.
Report Scope
The Heartworm Injections market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Heartworm Injections market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Heartworm Injections manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Boehringer Ingelheim
Zoetis
Merck Animal Health
Elanco
Virbac
Ceva Sante Animale S.A.
Segment by Type
Preventive
Therapeutic
Segment by Application
Dogs
Cats
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Heartworm Injections manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Heartworm Injections in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Heartworm injections are injections that are used to prevent and treat heartworm disease in dogs, cats, and other pets. They are administered by a veterinarian and are effective in preventing the development of heartworm infections in pets that are regularly treated. In addition, they can also be used to treat existing heartworm infections. These injections are administered on a regular basis, usually once or twice a month, and require a commitment from the pet owner to ensure effective treatment.
The global Heartworm Injections market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Heartworm Injections is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Heartworm Injections is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Heartworm Injections include Boehringer Ingelheim, Zoetis, Merck Animal Health, Elanco, Virbac and Ceva Sante Animale S.A., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Heartworm Injections, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Heartworm Injections.
Report Scope
The Heartworm Injections market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Heartworm Injections market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Heartworm Injections manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Boehringer Ingelheim
Zoetis
Merck Animal Health
Elanco
Virbac
Ceva Sante Animale S.A.
Segment by Type
Preventive
Therapeutic
Segment by Application
Dogs
Cats
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Heartworm Injections manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Heartworm Injections in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Heartworm Injections Market Overview
1.1 Product Overview and Scope of Heartworm Injections
1.2 Heartworm Injections Segment by Type
1.2.1 Global Heartworm Injections Market Value Comparison by Type (2024-2030)
1.2.2 Preventive
1.2.3 Therapeutic
1.3 Heartworm Injections Segment by Application
1.3.1 Global Heartworm Injections Market Value by Application: (2024-2030)
1.3.2 Dogs
1.3.3 Cats
1.3.4 Others
1.4 Global Heartworm Injections Market Size Estimates and Forecasts
1.4.1 Global Heartworm Injections Revenue 2019-2030
1.4.2 Global Heartworm Injections Sales 2019-2030
1.4.3 Global Heartworm Injections Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Heartworm Injections Market Competition by Manufacturers
2.1 Global Heartworm Injections Sales Market Share by Manufacturers (2019-2024)
2.2 Global Heartworm Injections Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Heartworm Injections Average Price by Manufacturers (2019-2024)
2.4 Global Heartworm Injections Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Heartworm Injections, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Heartworm Injections, Product Type & Application
2.7 Heartworm Injections Market Competitive Situation and Trends
2.7.1 Heartworm Injections Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Heartworm Injections Players Market Share by Revenue
2.7.3 Global Heartworm Injections Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Heartworm Injections Retrospective Market Scenario by Region
3.1 Global Heartworm Injections Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Heartworm Injections Global Heartworm Injections Sales by Region: 2019-2030
3.2.1 Global Heartworm Injections Sales by Region: 2019-2024
3.2.2 Global Heartworm Injections Sales by Region: 2025-2030
3.3 Global Heartworm Injections Global Heartworm Injections Revenue by Region: 2019-2030
3.3.1 Global Heartworm Injections Revenue by Region: 2019-2024
3.3.2 Global Heartworm Injections Revenue by Region: 2025-2030
3.4 North America Heartworm Injections Market Facts & Figures by Country
3.4.1 North America Heartworm Injections Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Heartworm Injections Sales by Country (2019-2030)
3.4.3 North America Heartworm Injections Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Heartworm Injections Market Facts & Figures by Country
3.5.1 Europe Heartworm Injections Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Heartworm Injections Sales by Country (2019-2030)
3.5.3 Europe Heartworm Injections Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Netherlands
3.6 Asia Pacific Heartworm Injections Market Facts & Figures by Country
3.6.1 Asia Pacific Heartworm Injections Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Heartworm Injections Sales by Country (2019-2030)
3.6.3 Asia Pacific Heartworm Injections Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Southeast Asia
3.6.9 China Taiwan
3.6.10 Australia
3.7 Latin America Heartworm Injections Market Facts & Figures by Country
3.7.1 Latin America Heartworm Injections Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Heartworm Injections Sales by Country (2019-2030)
3.7.3 Latin America Heartworm Injections Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Heartworm Injections Market Facts & Figures by Country
3.8.1 Middle East and Africa Heartworm Injections Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Heartworm Injections Sales by Country (2019-2030)
3.8.3 Middle East and Africa Heartworm Injections Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Heartworm Injections Sales by Type (2019-2030)
4.1.1 Global Heartworm Injections Sales by Type (2019-2024)
4.1.2 Global Heartworm Injections Sales by Type (2025-2030)
4.1.3 Global Heartworm Injections Sales Market Share by Type (2019-2030)
4.2 Global Heartworm Injections Revenue by Type (2019-2030)
4.2.1 Global Heartworm Injections Revenue by Type (2019-2024)
4.2.2 Global Heartworm Injections Revenue by Type (2025-2030)
4.2.3 Global Heartworm Injections Revenue Market Share by Type (2019-2030)
4.3 Global Heartworm Injections Price by Type (2019-2030)
5 Segment by Application
5.1 Global Heartworm Injections Sales by Application (2019-2030)
5.1.1 Global Heartworm Injections Sales by Application (2019-2024)
5.1.2 Global Heartworm Injections Sales by Application (2025-2030)
5.1.3 Global Heartworm Injections Sales Market Share by Application (2019-2030)
5.2 Global Heartworm Injections Revenue by Application (2019-2030)
5.2.1 Global Heartworm Injections Revenue by Application (2019-2024)
5.2.2 Global Heartworm Injections Revenue by Application (2025-2030)
5.2.3 Global Heartworm Injections Revenue Market Share by Application (2019-2030)
5.3 Global Heartworm Injections Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Boehringer Ingelheim
6.1.1 Boehringer Ingelheim Corporation Information
6.1.2 Boehringer Ingelheim Description and Business Overview
6.1.3 Boehringer Ingelheim Heartworm Injections Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Boehringer Ingelheim Heartworm Injections Product Portfolio
6.1.5 Boehringer Ingelheim Recent Developments/Updates
6.2 Zoetis
6.2.1 Zoetis Corporation Information
6.2.2 Zoetis Description and Business Overview
6.2.3 Zoetis Heartworm Injections Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Zoetis Heartworm Injections Product Portfolio
6.2.5 Zoetis Recent Developments/Updates
6.3 Merck Animal Health
6.3.1 Merck Animal Health Corporation Information
6.3.2 Merck Animal Health Description and Business Overview
6.3.3 Merck Animal Health Heartworm Injections Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merck Animal Health Heartworm Injections Product Portfolio
6.3.5 Merck Animal Health Recent Developments/Updates
6.4 Elanco
6.4.1 Elanco Corporation Information
6.4.2 Elanco Description and Business Overview
6.4.3 Elanco Heartworm Injections Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Elanco Heartworm Injections Product Portfolio
6.4.5 Elanco Recent Developments/Updates
6.5 Virbac
6.5.1 Virbac Corporation Information
6.5.2 Virbac Description and Business Overview
6.5.3 Virbac Heartworm Injections Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Virbac Heartworm Injections Product Portfolio
6.5.5 Virbac Recent Developments/Updates
6.6 Ceva Sante Animale S.A.
6.6.1 Ceva Sante Animale S.A. Corporation Information
6.6.2 Ceva Sante Animale S.A. Description and Business Overview
6.6.3 Ceva Sante Animale S.A. Heartworm Injections Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Ceva Sante Animale S.A. Heartworm Injections Product Portfolio
6.6.5 Ceva Sante Animale S.A. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Heartworm Injections Industry Chain Analysis
7.2 Heartworm Injections Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Heartworm Injections Production Mode & Process
7.4 Heartworm Injections Sales and Marketing
7.4.1 Heartworm Injections Sales Channels
7.4.2 Heartworm Injections Distributors
7.5 Heartworm Injections Customers
8 Heartworm Injections Market Dynamics
8.1 Heartworm Injections Industry Trends
8.2 Heartworm Injections Market Drivers
8.3 Heartworm Injections Market Challenges
8.4 Heartworm Injections Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
